Dr. Steve Henderson Joins Cizzle Bio as Senior Consultant, Grant Writing & Research

 
 

Cizzle Bio is pleased to welcome Dr. Steve Henderson as our Senior Consultant, Grant Writing & Research. With a distinguished background in biomedical research, clinical trials, and scientific communication, Dr. Henderson brings a wealth of expertise that will support Cizzle Bio’s mission to advance early cancer detection through innovative biomarker-based diagnostics.

A Strong Foundation in Research & Scientific Communication

Dr. Henderson earned his Ph.D. from the University of California at San Diego and San Diego State University, where he also served as an adjunct professor. His career spans multiple disciplines within medical writing and research, including:

  • Clinical trials for Alzheimer’s Disease

  • Co-authoring research and book chapters on neurological injury and treatment outcomes

  • Editing journal articles, books, and clinical trial protocols

  • Writing and securing grants for scientific research (e.g., NIH, SBIR, DOD)

  • Blogging about cancer clinical trials and medical advancements

His ability to simplify complex scientific concepts and translate research into funding opportunities and impactful publications makes him a valuable asset to Cizzle Bio’s research initiatives.

Driving Innovation Through Collaboration

Beyond his research and writing expertise, Dr. Henderson has played an active role in guiding scientific initiatives by serving on numerous boards and steering committees. His strategic problem-solving skills and collaborative mindset make him a key contributor in shaping research priorities, securing critical funding, and advancing groundbreaking projects.

Bill Behnke, Cizzle Bio’s Chairman and CEO, commented:

“Excited to have Steve on board—he quickly grasped the amazing work we are doing at Cizzle Bio and jumped in with both feet, working very well with our clinical and BD team.”

His ability to work seamlessly with cross-functional teams ensures that Cizzle Bio continues to make strides in early cancer detection and biomarker development.

Advancing Cizzle Bio’s Mission in Cancer Diagnostics

As Cizzle Bio continues to expand its research and development efforts, Dr. Henderson’s expertise in grant writing and biomedical research will be instrumental in:

  • Securing funding for innovative cancer diagnostics and biomarker research

  • Effectively communicating research breakthroughs to key stakeholders

  • Supporting clinical trials & regulatory documentation

His leadership will play a crucial role in strengthening Cizzle Bio’s position as a leader in early cancer detection technologies.

Looking Ahead

Dr. Henderson’s addition to our team marks an exciting step forward as we continue to innovate in lung and gastrointestinal cancer diagnostics. We are excited to have his expertise guiding our research efforts and look forward to achieving new milestones in early cancer detection.

Please join us in welcoming Dr. Steve Henderson to the Cizzle Bio team!

Cizzle Bio, Inc.

Cizzle Bio, Inc. is a pioneering biotechnology company focused on developing innovative solutions for early lung cancer detection. With a commitment to advancing cancer diagnostics, Cizzle Bio, Inc. collaborates with leading research institutions and healthcare professionals to bring groundbreaking biomarker blood tests to market, aiming to improve patient outcomes and save lives.

https://www.cizzlebio.com
Previous
Previous

Yolanda Heiberger Joins Cizzle Bio as Vice President of Communications & Patient Education

Next
Next

Dr. Steven T. Rosen Joins Cizzle Bio as Scientific Advisor